与古巴旅行相关的甲肝暴发——佛罗里达州,2024年6月至2026年2月
佛罗里达州卫生部门调查2024年6月至2026年2月期间确诊的249例甲肝病例,发现76例(31%)发病前有古巴旅行史,基因测序结果与古巴多地区广泛传播相符。CDC建议旅行前接种甲肝疫苗或免疫球蛋白,临床应询问旅行史以助诊断。
要点
- 佛罗里达州249例确诊甲肝中76例(31%)有古巴旅行史。
- 病例以男性(70%)、西班牙裔或拉丁裔(92%)为主,中位年龄39岁。
- CDC建议赴古巴旅行前接种甲肝疫苗或使用免疫球蛋白。
核心结论
- 佛罗里达州甲肝病例中约三成与古巴旅行相关,基因型结果提示古巴多地区广泛传播。
- 临床应关注从古巴返回的甲肝疑似病例并详细采集旅行史。
研究设计与样本
- 佛罗里达州卫生部门对2024年6月至2026年2月确诊的249例甲肝病例开展调查。
- 对部分病例进行补充旅行问卷和甲肝病毒基因分型。
主要发现
- 249例确诊病例中76例(31%)报告发病前有古巴旅行史。
- 古巴旅行相关病例中位年龄39岁,70%为男性,87%为白人,92%为西班牙裔或拉丁裔。
- 病例分布于佛罗里达州67个县中的13个(19%)。
- 29例完成补充旅行问卷者中55%曾到访哈瓦那,其他目的地包括8个古巴省份。
- 18株分离株基因分型:15株(83%)与IA型暴发株1匹配,2株(11%)与IB型株1匹配,1株(6%)与IA型株2匹配。
关键数值与推荐
- CDC建议前往古巴旅行前接种甲肝疫苗或接受免疫球蛋白。
- 对从古巴返回且出现甲肝相符症状和体征的患者,应考虑甲肝并询问详细旅行史。
临床怎么用
- 临床医生接诊有甲肝症状的患者时应主动询问古巴旅行史。
- 建议计划赴古巴旅行者提前接种甲肝疫苗或使用免疫球蛋白。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Beginning in early 2025, Florida Department of Health (FDOH) staff members noted an unusually high proportion of reported hepatitis A cases among travelers who had recently been in Cuba. Hepatitis A outbreaks have been reported in Cuban local news media; however, government reports are limited. FDOH investigated to characterize hepatitis A cases associated with travel to Cuba among Florida residents (including four patients who had recently emigrated from Cuba). FDOH found that among 249 confirmed hepatitis A cases identified during June 2024-February 2026, 76 (31%) patients reported recent travel to Cuba before symptom onset. Among patients with Cuba travel-associated hepatitis A, the median age was 39 years, 70% were male, 87% were White, and 92% were Hispanic or Latino. Patients lived in 13 (19%) of Florida's 67 counties. Among 29 patients who completed supplemental travel questionnaires, 55% had visited Havana; other travel destinations included eight additional Cuban provinces. Hepatitis A virus (HAV) genotyping of 18 isolates from unique patients with outbreak-associated cases identified 15 (83%) isolates that matched HAV genotype IA outbreak strain 1, two (11%) that matched IB strain 1, and one (6%) that matched IA strain 2. These findings are consistent with what would be expected were widespread hepatitis A transmission affecting multiple regions of Cuba. CDC recommends hepatitis A vaccination or receipt of immune globulin before travel to Cuba. Providers' consideration of hepatitis A among patients returning from Cuba who have hepatitis A-compatible signs and symptoms, together with elicitation of a detailed travel history, might aid diagnosis of Cuba travel-associated cases.
引用
- Linwong NN, Etienne MK, Llau A, et al. Hepatitis A Outbreak Associated with Cuba - Florida, June 2024-February 2026. MMWR Morb Mortal Wkly Rep. 2026. PMID: 42784526. doi:10.15585/mmwr.mm7537a1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。